2007年，巴西曾绕开了默克公司的抗艾药物依非韦仑的专利，转而从印度进口了一种较为廉价的非专利药物。
In 2007, Brazil sidestepped a patent on Merck & Co Inc's AIDS drug Efavirenz to import a cheaper generic drug from India.
默克公司说他们已经把依法韦仑的价格降低了，并且愿意进一步降低他的价格，但是默克的价格显然不能满足巴西人的需要。
Merck says it had already reduced the price of Efavirenz and was willing to cut further, but not enough to satisfy Brasilia.
应用推荐